Harvest Fund Management Co. Ltd Has $656,000 Stock Position in Masimo Co. (NASDAQ:MASI)

Harvest Fund Management Co. Ltd boosted its stake in Masimo Co. (NASDAQ:MASI) by 339.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,891 shares of the medical equipment provider’s stock after purchasing an additional 3,005 shares during the quarter. Harvest Fund Management Co. Ltd’s holdings in Masimo were worth $656,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of MASI. KBC Group NV raised its stake in Masimo by 17.3% in the third quarter. KBC Group NV now owns 1,280 shares of the medical equipment provider’s stock valued at $171,000 after purchasing an additional 189 shares in the last quarter. CIBC Asset Management Inc acquired a new position in Masimo in the third quarter valued at about $206,000. Empowered Funds LLC acquired a new position in Masimo in the third quarter valued at about $279,000. Quest Partners LLC raised its stake in Masimo by 8,360.0% in the third quarter. Quest Partners LLC now owns 2,115 shares of the medical equipment provider’s stock valued at $282,000 after purchasing an additional 2,090 shares in the last quarter. Finally, Avior Wealth Management LLC raised its stake in Masimo by 16.5% in the third quarter. Avior Wealth Management LLC now owns 5,731 shares of the medical equipment provider’s stock valued at $764,000 after purchasing an additional 812 shares in the last quarter. Institutional investors and hedge funds own 85.96% of the company’s stock.

Insider Activity at Masimo

In related news, COO Bilal Muhsin sold 30,000 shares of the company’s stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $167.49, for a total value of $5,024,700.00. Following the sale, the chief operating officer now directly owns 24,172 shares in the company, valued at $4,048,568.28. This represents a 55.38 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Craig B. Reynolds sold 2,053 shares of the company’s stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $166.13, for a total value of $341,064.89. Following the completion of the sale, the director now owns 16,581 shares in the company, valued at $2,754,601.53. The trade was a 11.02 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 9.70% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of research analysts recently commented on the company. Wells Fargo & Company boosted their price target on Masimo from $193.00 to $205.00 and gave the company an “overweight” rating in a research note on Wednesday, February 26th. Piper Sandler lifted their target price on Masimo from $210.00 to $215.00 and gave the company an “overweight” rating in a research report on Wednesday, February 26th. Needham & Company LLC reiterated a “hold” rating on shares of Masimo in a research report on Wednesday, February 26th. Raymond James lifted their target price on Masimo from $170.00 to $194.00 and gave the company an “outperform” rating in a research report on Friday, December 27th. Finally, Stifel Nicolaus reiterated a “buy” rating and issued a $190.00 target price (up previously from $170.00) on shares of Masimo in a research report on Friday, November 22nd. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $194.80.

Masimo Stock Performance

NASDAQ:MASI opened at $169.50 on Friday. The stock has a market cap of $9.14 billion, a P/E ratio of 116.90 and a beta of 1.04. The company has a current ratio of 2.01, a quick ratio of 1.11 and a debt-to-equity ratio of 0.50. The stock’s 50-day moving average is $175.00 and its 200-day moving average is $158.86. Masimo Co. has a 1-year low of $101.61 and a 1-year high of $194.88.

Masimo (NASDAQ:MASI) last released its quarterly earnings results on Tuesday, February 25th. The medical equipment provider reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.38. The company had revenue of $600.70 million for the quarter, compared to analysts’ expectations of $593.35 million. Masimo had a return on equity of 14.98% and a net margin of 3.85%. Equities research analysts anticipate that Masimo Co. will post 4.1 earnings per share for the current year.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.